-
Join 357 other subscribers
Blogroll
HIV/AIDS networks
Links
- bilaterals.org
- Fix the Patent Laws!
- FTA Malaysia
- HAI Europe
- Health Action International (HAI)
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS
- MSF Access Campaign
- Patent Opposition Database
- Public Citizen
- Stop EU-India FTA
- Stop Peru FTA
- Third World Network
- Treatment Action Group
- UAEM Europe
- UAEM evidence collection
- Universities Allied for Essential Medicines (UAEM)
Archives
-
Recent Posts
- Clamour against United Kingdom’s free-trade negotiator
- India, EU conclude another round of talks for proposed trade agreement
- Next round of India, UK talks for free trade agreement to be held in March
- ‘Playing with the lives of HIV patients’: Drug shortages force many to change medication regime
- Pfizer’s Covid pill Paxlovid gets WHO’s approval. All you need to know
Categories
Category Archives: Protest&Campaigns
Reminder! Register for panel event WHA72 Friday , 24 May on CART and CRISPR
Source: Keionline 21st May, 2019 24 May 2019- KEI panel discussion- Assessing the implications of the development of new cell and gene-based therapies (including CART and CRISPR): What role should WHO play? On Friday, 24 May 2019, Knowledge Ecology International … Continue reading
Posted in Access to Medicins, IP Rights, Upcoming events
Leave a comment
RCEP and affordable medicines: Civil society reaches out to Minister of Commerce Suresh Prabhu
12th Nov 2018, New Delhi The RCEP ministerial meeting is taking place today, 12th November, 2018 in Singapore. It will be followed by Leaders’ Summit on 14th November. There are clear indications that countries want to wrap up the negotiations that started in … Continue reading
Most New Drug Patents Are for Old Remedies, Research Shows
Source: Bloomberg | November 1, 2018 The U.S. patent system was designed to protect new innovations, but drugmakers are more often than not using it to protect old ones. At least 74 percent of drugs associated with new patents were medicines … Continue reading
New laws needed now to save lives: FTPL statement on new IP policy
Source: Fix the Patent Laws Intellectual property policy welcomed after nine years of development JOHANNESBURG, 31 MAY 2018 – Yesterday, after nine years of development, the Department of Trade and Industry (the dti) finally published the Intellectual Property Policy of the … Continue reading
Patients Over Profits: Families Unite to Fight for Healthcare and Justice
Source: The Wire | May 27, 2018 New Delhi: Tragedies can be tipping points for change. And through their bereavements, four families have come together to demand accountability and change from the government as well as from private hospitals. They are … Continue reading
Posted in Letters to officials, Right to Health
Leave a comment
South African Cabinet approves new Intellectual Property Policy
Source: Fix the Patent Laws | May 24, 2018 The Fix the Patent Laws Coalition (FTPL) welcomes the news today that the Cabinet of the Government of South Africa has approved the new Intellectual Property (IP) Policy. After nine years of … Continue reading
Posted in Africa, Fix the patent law, IPR policy, Patent, Uncategorized
Leave a comment
Report on Pharmaceutical Patents in India – How our safeguards against evergreening have failed, and why the system must be reformed
The recent report on “Pharmaceutical Patent Grants in India How our safeguards against evergreening have failed, and why the system must be reformed” shows immense irregularities in grant of patents in the country. Over the past decades India’s patent system has … Continue reading
72% of drug patent grants in India for marginal improvements, says study
Source: Business Today | April 25, 2018 Majority of pharmaceutical drug patents granted by India might have skipped elaborate scrutiny, an analysis of patent grants by a team of researchers and patent lawyers reveals. The report which studied the prosecution history of … Continue reading
Scottish Compulsory Licensing campaign launches today
Highlighting a new campaign aimed at the Scottish government on the price of Roche’s pertuzumab for breast cancer Dunise is a Scottish woman with breast cancer. Right now she is getting access to a drug pertuzumab (Perjeta) because she live in England.
Roche vs Indian Pharma: The battle for a cheaper cancer drug
By Divya Rajagopal, The Economic Times|May 14, 2017 Let’s hark back to the Nineties. The HIV-AIDS epidemic was spreading across Africa, leaving thousands dead, in spite of the existence of anti-retroviral drugs (ARVs). The cost of the treatment, around $10,000, … Continue reading